[Blood transfusion therapy for massive hemorrhage associated with scheduled peritonectomy for pseudomyxoma peritonei and peritoneal dissemination].

Background: The component therapy has been recommended for surgical hemorrhage. We investigated whether the component therapy was useful for surgical patients undergoing the scheduled peritonectomy for pseudomyxoma peritonei or peritoneal dissemination.

Methods: Twenty patients were divided into two groups (the component therapy for 7 patients and the early transfusion of flesh frozen plasma therapy for 13 patients).